Pharma & Biotech

The pharmaceutical industry continues to scrutinize Vertex Pharmaceuticals' landmark acquisition of Alpine Immune Sciences, a transaction valued at $4.9 billion...

Biotechnology firm Ocugen Inc. finds itself navigating a critical juncture. While the company's latest earnings report revealed substantial revenue growth,...

Eli Lilly and Company has positioned itself for substantial expansion through a series of strategic developments announced in early November...

While NextCure shares extended their positive momentum with a fourth consecutive day of gains, underlying technical indicators reveal concerning divergences...

The biotechnology firm Lyra Therapeutics Inc finds itself navigating turbulent waters, with its equity valuation under severe pressure. A combination...

The French vaccine developer Valneva has staged an impressive financial recovery, transforming a €69.3 million loss into a substantial €24.7...

Redcare Pharmacy shares are navigating turbulent waters, having shed more than half their value since the start of the year...

A seismic development has rocked BioNTech's stock valuation following the complete divestment of Pfizer's substantial shareholding. The long-standing pandemic partner...

In a strategic move signaling its digital ambitions, Redcare Pharmacy has appointed Hendrik Krampe, an e-commerce specialist with extensive experience...

The biotechnology sector is renowned for its volatility, but the upcoming financial report from Valneva could unsettle even the most...